Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Omeros Corp.

Sector: Pharmaceutical Preparations Region: WA, United States


Exchange/Ticker: Nasdaq: OMER


Company Description

Omeros Corp. is a clinical stage biopharmaceutical company engages in discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The company's products are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. It also has a deep and diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Similar to: AstraZeneca Plc, Sanofi, NPS Pharmaceuticals, Inc.

Featured Company


Aberdeen Private Equity Fund Ltd.

London, Guernsey , GG

**Objective of Aberdeen Private Equity Fund** The investment objective of the Company is to generate long-term capital gains. … Learn more →

You may also be interested in:


NPS Pharmaceuticals, Inc.

Bedminster, NJ, US

NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →

Sanofi

Paris, FR

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →

AstraZeneca Plc

London, LO, GB

AstraZeneca Plc is a global research-based biopharmaceutical company, which discovers, develops and markets medicines for gastrointestinal,… Learn more →